Buprenorphine Sublingual C-III 2 mg/1
Buprenorphine Sublingual C-III · TABLET · Direct_Rx
Buprenorphine Sublingual C-III is a prescription tablet containing buprenorphine sublingual c-iii at 2 mg/1, taken sublingual. Manufactured by Direct_Rx.
Key Facts
- Brand Name
- Buprenorphine Sublingual C-III
- Generic Name
- Buprenorphine Sublingual C-III
- NDC Code (Product)
72189-580- Manufacturer
- Direct_Rx
- Strength
- 2 mg/1
- Dosage Form
- TABLET
- Route
- SUBLINGUAL
- Marketing Status
- HUMAN PRESCRIPTION DRUG
- DEA Schedule
- Schedule III (Controlled)
- Application #
- ANDA078633
- Drug Class
- Partial Opioid Agonist [EPC]; Partial Opioid Agonists [MoA]
- Marketing Start
- 09/16/2024
Recall History
No Recall HistoryFrequently Asked Questions
What is Buprenorphine Sublingual C-III used for?
Buprenorphine Sublingual C-III contains Buprenorphine Sublingual C-III. It is a tablet taken sublingual. Consult your doctor for specific uses.
Is Buprenorphine Sublingual C-III a controlled substance?
Yes, Buprenorphine Sublingual C-III is classified as CIII under the DEA Controlled Substances Act.
What is the generic name for Buprenorphine Sublingual C-III?
The generic name for Buprenorphine Sublingual C-III is Buprenorphine Sublingual C-III. There are no other listed brand versions of Buprenorphine Sublingual C-III.
What is the NDC code for Buprenorphine Sublingual C-III 2 mg/1?
The NDC (National Drug Code) for Buprenorphine Sublingual C-III 2 mg/1 is 72189-580, listed by Direct_Rx.
Other Buprenorphine Sublingual C-III Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)